dc.contributor.author |
Adetunji, O
|
|
dc.contributor.author |
Adeniyi, O
|
|
dc.contributor.author |
Botha, Adèle
|
|
dc.contributor.author |
Herselman, Martha E
|
|
dc.date.accessioned |
2023-07-12T10:06:19Z |
|
dc.date.available |
2023-07-12T10:06:19Z |
|
dc.date.issued |
2022-12 |
|
dc.identifier.citation |
Adetunji, O., Adeniyi, O., Botha, A. & Herselman, M.E. 2022. Medication nonadherence in TB patients: Innovative technology use and related legal framework. http://hdl.handle.net/10204/12879 . |
en_ZA |
dc.identifier.uri |
979-8-3503-2028-2
|
|
dc.identifier.uri |
http://hdl.handle.net/10204/12879
|
|
dc.description.abstract |
Tuberculosis is a deadly disease that has been at the forefront of many deaths around the world, but patient nonadherence to medication has been a foremost contributor to this result. Nonetheless, there could be innovative, technological intervention to aid patients’ adherence to medication and prevent the many deaths. However, some of the medication nonadherence causes as well as technological interventions could have legal consequences, but the impact of this has not been investigated, especially with regards to the impact on the human rights of the patients and on the society. The article is written to add to the body of expertise on the topic and will be useful for policymakers and all stakeholders in the related area of using technology to improve patient health in the bid to attain the Sustainable Development Goals of bringing an end to the tuberculosis epidemic by 2030 (SDGs). |
en_US |
dc.format |
Abstract |
en_US |
dc.language.iso |
en |
en_US |
dc.relation.uri |
https://american-cse.org/csci2022-ieee/pdfs/CSCI2022-2lPzsUSRQukMlxf8K2x89I/202800b713/202800b713.pdf |
en_US |
dc.relation.uri |
https://american-cse.org/csci2022/ |
en_US |
dc.source |
The 2022 International Conference on Computational Science and Computational Intelligence, CSCI'22, Las Vegas, USA, 14-16 December 2022 |
en_US |
dc.subject |
Technological innovation |
en_US |
dc.subject |
Data protection |
en_US |
dc.subject |
Legal framework |
en_US |
dc.subject |
Medication nonadherence |
en_US |
dc.subject |
Right to privacy |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.title |
Medication nonadherence in TB patients: Innovative technology use and related legal framework |
en_US |
dc.type |
Conference Presentation |
en_US |
dc.description.pages |
8 |
en_US |
dc.description.note |
©2022 IEEE. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, please consult the publisher's website: https://american-cse.org/csci2022-ieee/pdfs/CSCI2022-2lPzsUSRQukMlxf8K2x89I/202800b713/202800b713.pdf https://american-cse.org/csci2022/ |
en_US |
dc.description.cluster |
Next Generation Enterprises & Institutions |
en_US |
dc.description.impactarea |
Software Architectures Solutions |
en_US |
dc.description.impactarea |
Technology Implementation ME |
en_US |
dc.identifier.apacitation |
Adetunji, O., Adeniyi, O., Botha, A., & Herselman, M. E. (2022). Medication nonadherence in TB patients: Innovative technology use and related legal framework. http://hdl.handle.net/10204/12879 |
en_ZA |
dc.identifier.chicagocitation |
Adetunji, O, O Adeniyi, Adele Botha, and Martha E Herselman. "Medication nonadherence in TB patients: Innovative technology use and related legal framework." <i>The 2022 International Conference on Computational Science and Computational Intelligence, CSCI'22, Las Vegas, USA, 14-16 December 2022</i> (2022): http://hdl.handle.net/10204/12879 |
en_ZA |
dc.identifier.vancouvercitation |
Adetunji O, Adeniyi O, Botha A, Herselman ME, Medication nonadherence in TB patients: Innovative technology use and related legal framework; 2022. http://hdl.handle.net/10204/12879 . |
en_ZA |
dc.identifier.ris |
TY - Conference Presentation
AU - Adetunji, O
AU - Adeniyi, O
AU - Botha, Adele
AU - Herselman, Martha E
AB - Tuberculosis is a deadly disease that has been at the forefront of many deaths around the world, but patient nonadherence to medication has been a foremost contributor to this result. Nonetheless, there could be innovative, technological intervention to aid patients’ adherence to medication and prevent the many deaths. However, some of the medication nonadherence causes as well as technological interventions could have legal consequences, but the impact of this has not been investigated, especially with regards to the impact on the human rights of the patients and on the society. The article is written to add to the body of expertise on the topic and will be useful for policymakers and all stakeholders in the related area of using technology to improve patient health in the bid to attain the Sustainable Development Goals of bringing an end to the tuberculosis epidemic by 2030 (SDGs).
DA - 2022-12
DB - ResearchSpace
DP - CSIR
J1 - The 2022 International Conference on Computational Science and Computational Intelligence, CSCI'22, Las Vegas, USA, 14-16 December 2022
KW - Technological innovation
KW - Data protection
KW - Legal framework
KW - Medication nonadherence
KW - Right to privacy
KW - Tuberculosis
LK - https://researchspace.csir.co.za
PY - 2022
T1 - Medication nonadherence in TB patients: Innovative technology use and related legal framework
TI - Medication nonadherence in TB patients: Innovative technology use and related legal framework
UR - http://hdl.handle.net/10204/12879
ER - |
en_ZA |
dc.identifier.worklist |
26638 |
en_US |